Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-03 Sale |
2025-01-07 8:04 pm |
Cartesian Therapeutics Inc. | RNAC | Davis Blaine Chief Financial Officer |
7,989 | $16.78 | $134,036 | 94,811 (Direct) |
View |
| 2020-09-22 Purchase |
2020-09-23 09:20 am |
Protara Therapeutics Inc. | TARA | Davis Blaine Chief Financial Officer |
1,481 | $16.91 | $25,038 | 1,481 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-02 Option Award |
2025-01-06 4:20 pm |
N/A 2035-01-01 |
Cartesian Therapeutics Inc. | RNAC | Davis Blaine Chief Financial Officer |
86,600 | $0 | 271,066 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 5:08 pm |
N/A 2034-01-01 |
Cartesian Therapeutics Inc. | RNAC | Davis Blaine Chief Financial Officer |
5,534,000 | $0 | 5,534,000 (Direct) |
View |
| 2022-11-28 Option Award |
2022-11-30 4:40 pm |
N/A 2032-11-27 |
SELECTA BIOSCIENCES INC | SELB | Davis Blaine Chief Financial Officer |
1,250,000 | $0 | 1,250,000 (Direct) |
View |
| 2022-07-15 Tax Withholding |
2022-07-19 4:31 pm |
N/A N/A |
Protara Therapeutics Inc. | TARA | Davis Blaine Chief Financial Officer |
5,081 | $3.13 | 20,662 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:35 pm |
N/A 2032-01-02 |
Protara Therapeutics Inc. | TARA | Davis Blaine Chief Financial Officer |
98,900 | $0 | 100,381 (Direct) |
View |
| 2021-01-19 Option Award |
2021-01-21 3:05 pm |
N/A 2031-01-18 |
Protara Therapeutics Inc. | TARA | Davis Blaine Chief Financial Officer |
75,000 | $0 | 75,000 (Direct) |
View |